Agmatine is not a good candidate as endogenous ligand for imidazoline sites of pancreatic B cells and vascular bed

This publication has 10 references indexed in Scilit:

• Inhibitory presynaptic imidazoline receptors on sympathetic nerves in the rabbit aorta differ from I1- and I2-imidazoline binding sites
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1995
• Evidence for two different imidazoline sites on pancreatic B cells and vascular bed in rat
  European Journal of Pharmacology, 1995
• Agmatine recognizes ?2-adrenoceptor binding sites but neither activates nor inhibits ?2-adrenoceptors
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1995
• Effects of imidazolines and derivatives on insulin secretion and vascular resistance in perfused rat pancreas
  European Journal of Pharmacology, 1994
• Agmatine: an Endogenous Clonidine-Displacing Substance in the Brain
  Science, 1994
• Imidazoline antagonists of α₂‐adrenoceptors increase insulin release in vitro by inhibiting ATP‐sensitive K⁺ channels in pancreatic β‐cells
  British Journal of Pharmacology, 1992
• Keeping an eye on the I site: imidazoline-prefemng receptors
  Trends in Pharmacological Sciences, 1992
• The α2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells
  European Journal of Pharmacology, 1991
• An insulin-releasing property of imidazoline derivatives is not limited to compounds that block ?-adrenoceptors
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1989
• Stimulus-secretion coupling of arginine-induced insulin release
  Biochemical Pharmacology, 1989